A Phase 2 Study of Pyrotinib in Patients With Advanced/ Metastatic HER2-Altered Biliary Tract Cancers Who Have Failed One or Two Prior Lines of Therapies
Latest Information Update: 07 Sep 2022
At a glance
- Drugs Pyrotinib (Primary)
- Indications Biliary cancer
- Focus Therapeutic Use
- Sponsors Jiangsu Hengrui Medicine Co.
- 06 Oct 2020 New trial record